Cargando…
Targeted Protein Degradation: Clinical Advances in the Field of Oncology
The field of targeted protein degradation (TPD) is a rapidly developing therapeutic modality with the promise to tame disease-relevant proteins in ways that are difficult or impossible to tackle with other strategies. While we move into the third decade of TPD, multiple degrader drugs have entered t...
Autores principales: | Salama, Abdelrahman K. A. A., Trkulja, Marija V., Casanova, Emilio, Uras, Iris Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741350/ https://www.ncbi.nlm.nih.gov/pubmed/36499765 http://dx.doi.org/10.3390/ijms232315440 |
Ejemplares similares
-
Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
por: Uras, Iris Z., et al.
Publicado: (2020) -
STAT3: Versatile Functions in Non-Small Cell Lung Cancer
por: Mohrherr, Julian, et al.
Publicado: (2020) -
Advances in targeted degradation of endogenous proteins
por: Röth, Sascha, et al.
Publicado: (2019) -
The clinical advances of proteolysis targeting chimeras in oncology
por: Xie, Hao, et al.
Publicado: (2021) -
Recent Advances of Magnetic Nanomaterials in the Field of Oncology
por: Li, Tianyang, et al.
Publicado: (2020)